Comparison
2q13 Microdeletion Syndrome C6012360 vs 11p15 4 Microduplication Syndrome C4749508
Clinical comparison between 2q13 Microdeletion Syndrome and 11p15 4 Microduplication Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
11p15 4 Microduplication Syndrome C4749508
A rare genetic disorder involving duplication of material on chromosome 11, leading to varied developmental features. Requires individualized medical assessment.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
11p15 4 Microduplication Syndrome C4749508
0-null
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
11p15 4 Microduplication Syndrome C4749508
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
11p15 4 Microduplication Syndrome C4749508
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
11p15 4 Microduplication Syndrome C4749508
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
11p15 4 Microduplication Syndrome C4749508
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
11p15 4 Microduplication Syndrome C4749508
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 11p15-4-microduplication-syndrome-C4749508 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 11p15 4 Microduplication Syndrome C4749508 | Discriminating power |
|---|---|---|---|
| Chromosomal change | Missing material at 2q13 | Extra material at 11p15.4 | High |
| Development | May affect development; pattern not established | Varied developmental features; pattern not established | Low |
| Severity label | Source label severe; individual course varies | Source label moderate; individual course varies | Moderate |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
A confirmed 2q13 deletion
The named deletion identifies this condition, not symptoms alone
High
Planning symptom-based specialist care
Source says care involves multiple specialists as needed
Moderate
Using age of onset to decide
Onset is listed as variable, so timing is not diagnostic
Low
Choose 11p15 4 Microduplication Syndrome C4749508 when
A confirmed 11p15.4 duplication
The named duplication distinguishes it from a 2q13 deletion
High
Features vary between patients
Source emphasizes varied features and individualized assessment
Moderate
Onset is unclear or recorded as null
Supplied onset is not interpretable and should not guide selection
Low
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 11p15 4 Microduplication Syndrome C4749508 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show a 2q13 deletion | May show an 11p15.4 duplication | Confirm and interpret clinically; an abnormal result alone is not the full diagnosis. |
| Karyotype | A small deletion may be missed | A small duplication may be missed | A normal karyotype does not exclude either micro-change. |
| Clinical genetics review | Correlate deletion with individual findings | Correlate duplication with individual findings | No definitive symptom set or laboratory cutoff is established here. |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- Long-term outcome is not established; source severity label is severe.
- Factors
- Confirmed deletion, affected systems, and available supports.
11p15 4 Microduplication Syndrome C4749508
- Outcome
- Long-term outcome is not established; source severity label is moderate.
- Factors
- Confirmed duplication, variable features, and individualized care.
Time frame: A chronic course is suggested, but timelines are not established.
Do not infer mortality or function from severity labels alone.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Possible; extent not established Possible and variable; extent not established Do not assume complications without individual assessment. |
| Distinctive features | Source mentions possible distinctive features Not specifically established in the source Examination is required; features do not replace genetic confirmation. |
| Care complexity | May require several specialists Requires individualized assessment Complication rates and mortality are not supplied. |
Patient education highlights
- HighMeaning of the result
This is a chromosomal finding. A clinician should explain its meaning for the individual.
- HighTransmission
Neither condition is communicable according to the supplied data.
- MediumCare planning
Support follows the person's symptoms. Doses and numeric prognosis are not established here.